Aldeyra Therapeutics (ALDX) Shares Issued (2013 - 2026)
Aldeyra Therapeutics' (ALDX) quarterly Shares Issued came in at $10.0 million in Q1 2026, up 20.03% YoY from $8.3 million in Q1 2025, and up 16.59% on a QoQ basis from $8.6 million in Q4 2025.
Aldeyra Therapeutics (ALDX) Shares Issued (2013 - 2026) Analysis & Trends
Aldeyra Therapeutics (ALDX) has 14 years of Shares Issued data on file, last reported at $10.0 million in Q1 2026.
- Quarterly Shares Issued rose 20.03% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.0 million (up 20.03% YoY) and the FY2025 annual result came in at $8.6 million, up 12.61% from the prior year.
- Shares Issued climbed to $10.0 million in Q1 2026, from $8.6 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $10.0 million in Q1 2026 to a low of $3.3 million in Q3 2022.
- A 5-year average of $6.6 million and a median of $6.4 million in 2023 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2022 — Shares Issued surged 134.49% — and 2024, when it dropped 29.69%.
- Tracing ALDX's Shares Issued over 5 years: stood at $5.4 million in 2022, then grew by 8.6% to $5.9 million in 2023, then rose by 29.87% to $7.6 million in 2024, then climbed by 12.61% to $8.6 million in 2025, then increased by 16.59% to $10.0 million in 2026.
- The last three Shares Issued figures came in at $10.0 million (Q1 2026), $8.6 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Aldeyra Therapeutics | 90.18 Mn | 90.18 Mn | - | 9.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.28 Mn |
| Jun 30, 2026 | 9.28 Mn |
| Mar 31, 2026 | 10.01 Mn |
| Mar 31, 2026 | 10.01 Mn |
| Dec 31, 2025 | 8.58 Mn |
| Dec 31, 2025 | 8.58 Mn |
| Sep 30, 2025 | 8.59 Mn |
| Sep 30, 2025 | 8.59 Mn |
| Jun 30, 2025 | 8.61 Mn |
| Jun 30, 2025 | 8.61 Mn |
| Mar 31, 2025 | 8.34 Mn |
| Mar 31, 2025 | 8.34 Mn |
| Dec 31, 2024 | 7.62 Mn |
| Dec 31, 2024 | 7.62 Mn |
| Sep 30, 2024 | 5.12 Mn |
| Sep 30, 2024 | 5.12 Mn |
| Jun 30, 2024 | 8.03 Mn |
| Jun 30, 2024 | 8.03 Mn |
| Mar 31, 2024 | 4.52 Mn |
| Mar 31, 2024 | 4.52 Mn |